当前位置: 首页 > 期刊 > 《中国保健营养.中旬刊》 > 2014年第7期
编号:12810617
丹红注射液的临床应用研究进展(4)
http://www.100md.com 2014年7月1日 中国保健营养·中旬刊 2014年第7期
     [18] Zhao PX,Jiang S.Effect of danhong injection on ET-1, sP-sel, and hs-CRP in patients with acute coronary syndrome undergoing percutaneous coronary intervention[J].Zhongguo Zhong Xi Yi Jie He Za Zhi,2011,31(1):11-4.

    [19] 张永香,张强.丹红注射液对急性冠脉综合征患者介入治疗后的心肌保护作用[J].中国实验方剂学杂志,2012,18(23):308-309.

    [20] Zhao ZW,Cheng CS,Ma WL,et al.Danhong injection, ligustrazine injection, combined adsorbable biomembranes prevented adhesion of tendons after the repair operation: a clinical research[J].Zhongguo Zhong Xi Yi Jie He Za Zhi,2013,33(9):1212-5.

    [21] Zhi XW,Su XM,Feng WY,et al.Effect and mechanism of Danhong injection on isolated mesenteric arterial rings in rats[J].Zhongguo Zhong Yao Za Zhi,2012,37(17):2607-2611.

    [22] Wang D,Fan G,Wang Y,et al.Vascular reactivity screen of Chinese medicine danhong injection identifies Danshensu as a NO-independent but PGI2-mediated relaxation factor[J].Cardiovasc Pharmacol,2013,62(5):457-65.

    [23] Su X,Yang W,Zhi X.Effect of danhong injection on expressions of macrophage scavenger receptor 1 and sub-family A member 1 in human U937 cells[J].Tradit Chin Med,2013,33(3):384-7.

    [24] 石玉.浅议单硝酸异山梨酯与丹红注射液治疗肺心病[J].求医问药,2012,8 ( 10):428.

    [25] 陈倩,易丹辉,谢雁鸣,等.基于HIS“真实世界”的丹红注射液上市后临床应用分析[J]. 中国中药杂志,2011,36(20):2817-2820.

    [26] 李学林,唐进法,孟菲,等.10409例丹红注射液上市后安全性医院集中监测研究[J].中国中药杂志,2011,36(20):2783-2785., 百拇医药(何广宏 张晓宁)
上一页1 2 3 4